Biolidics Ltd. (8YY) Price & Analysis

Q: What was Biolidics Ltd.’s price range in the past 12 months?

Biolidics Ltd. lowest share price was S$0.01 and its highest was S$0.03 in the past 12 months.

Q: What is Biolidics Ltd.’s market cap?

Biolidics Ltd.’s market cap is S$38.14M.

Q: When is Biolidics Ltd.’s upcoming earnings report date?

Biolidics Ltd.’s upcoming earnings report date is Oct 29, 2025 which is 31 days ago.

Q: How were Biolidics Ltd.’s earnings last quarter?

Biolidics Ltd. released its earnings results on Aug 12, 2025. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.

Q: Is Biolidics Ltd. overvalued?

According to Wall Street analysts Biolidics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Biolidics Ltd. pay dividends?

Biolidics Ltd. does not currently pay dividends.

Q: What is Biolidics Ltd.’s EPS estimate?

Biolidics Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Biolidics Ltd. have?

Biolidics Ltd. has 1,733,441,800 shares outstanding.

Q: What happened to Biolidics Ltd.’s price movement after its last earnings report?

Biolidics Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Biolidics Ltd.?

Currently, no hedge funds are holding shares in SG:8YY

Compare

1 Followers

8YY Stock Chart & Stats

S$0.02

<S$0.01(3.70%)

At close: Jan 07 4:00 PM EST

S$0.02

<S$0.01(3.70%)

Day’s Range― - ―

52-Week RangeS$0.01 - S$0.03

Previous CloseN/A

Volume13.75M

Average Volume (3M)412.95K

Market Cap

S$38.14M

Enterprise ValueN/A

Total Cash (Recent Filing)S$300.00K

Total Debt (Recent Filing)S$2.52M

Price to Earnings (P/E)―

Beta0.39

Next Earnings

Oct 29, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding1,733,441,800

10 Day Avg. Volume410,990

30 Day Avg. Volume412,950

Financial Highlights & Ratios

PEG Ratio0.50

Price to Book (P/B)16.43

Price to Sales (P/S)36.30

P/FCF Ratio-12.27

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Biolidics Ltd. News

Embracing Future Holdings Expands Share Capital with New Issuance

Biolidics Ltd. ( ($SG:8YY) ) has provided an update. Embracing Future Holdings Limited has completed the allotment and...

4M ago

8YY

Embracing Future Holdings Secures SGX Approval for New Share Listings

Biolidics Ltd. ( ($SG:8YY) ) has shared an update. Embracing Future Holdings Limited has received approval from the...

4M ago

8YY

Embracing Future Holdings Conducts EGM for Key Resolutions

Biolidics Ltd. ( ($SG:8YY) ) just unveiled an announcement. Embracing Future Holdings Limited, formerly known as Biolidics Ltd.,...

5M ago

8YY

Embracing Future Holdings Issues New Shares for Professional Fees

An update from Biolidics Ltd. ( ($SG:8YY) ) is now available. Embracing Future Holdings Limited has announced the...

5M ago

8YY

Embracing Future Holdings Completes Strategic Share Subscription

The latest announcement is out from Biolidics Ltd. ( ($SG:8YY) ). Embracing Future Holdings Limited, previously known as...

5M ago

8YY

Biolidics Ltd. Conducts Annual General Meeting with Key Resolutions

An update from Biolidics Ltd. ( ($SG:8YY) ) is now available. Biolidics Ltd., a company incorporated in Singapore,...

6M ago

8YY

Biolidics Ltd. Announces Strategic Initiatives and Business Diversification

The latest announcement is out from Biolidics Ltd. ( ($SG:8YY) ). Biolidics Ltd. has announced several strategic initiatives,...

7M ago

8YY

Biolidics Completes Acquisition to Expand E-Sports Presence

Biolidics Ltd. (SG:8YY) has released an update. Biolidics Limited has successfully completed the acquisition of Shenzhen Xiaozhao Network...

1y ago

8YY

Biolidics Ltd. Approves Key Share Issuance and Transfer

Biolidics Ltd. (SG:8YY) has released an update. Biolidics Ltd. held an Extraordinary General Meeting where shareholders voted on...

1y ago

8YY

Biolidics Ltd. Completes Major Share Issuance

Biolidics Ltd. (SG:8YY) has released an update. Biolidics Limited has successfully completed the issuance and allotment of 946...

1y ago

8YY

8YY FAQ

What was Biolidics Ltd.’s price range in the past 12 months?

Biolidics Ltd. lowest share price was S$0.01 and its highest was S$0.03 in the past 12 months.

What is Biolidics Ltd.’s market cap?

Biolidics Ltd.’s market cap is S$38.14M.

When is Biolidics Ltd.’s upcoming earnings report date?

Biolidics Ltd.’s upcoming earnings report date is Oct 29, 2025 which is 31 days ago.

How were Biolidics Ltd.’s earnings last quarter?

Biolidics Ltd. released its earnings results on Aug 12, 2025. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.

Is Biolidics Ltd. overvalued?

According to Wall Street analysts Biolidics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biolidics Ltd. pay dividends?

Biolidics Ltd. does not currently pay dividends.

What is Biolidics Ltd.’s EPS estimate?

Biolidics Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biolidics Ltd. have?

Biolidics Ltd. has 1,733,441,800 shares outstanding.

What happened to Biolidics Ltd.’s price movement after its last earnings report?

Biolidics Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Biolidics Ltd.?

Currently, no hedge funds are holding shares in SG:8YY

Biolidics Ltd. Stock Smart Score

Underperform

Technicals

Top Smart Score Stocks >

Company Description

Biolidics Ltd.

Biolidics Ltd. (8YY) is a biotechnology company based in Singapore that specializes in the development and commercialization of innovative diagnostic solutions for the healthcare sector. The company focuses on providing advanced medical technologies, particularly in the areas of cancer diagnostics and the detection of infectious diseases. Biolidics' core products include its proprietary cancer detection assays and a range of diagnostic kits aimed at improving patient outcomes and streamlining healthcare processes.